Kun Shang
-
- interferon and immune responses 4
-
- Nanoplatforms for cancer theranostics 9
-
- Ubiquitin and proteasome pathways 3
- Cancer therapeutics and mechanisms 1
-
- Photodynamic Therapy Research Studies 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Lanthanide and Transition Metal Complexes 2
-
- Autophagy in Disease and Therapy 1
In The Last Decade
Kun Shang
13 papers receiving 374 citations
Peers
Comparison fields: 5 of 55
- Immunology 146
- Biomaterials 72
- Biomedical Engineering 211
- Physiology 10
- Molecular Biology 140
Countries citing papers authored by Kun Shang
This map shows the geographic impact of Kun Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Shang more than expected).
Fields of papers citing papers by Kun Shang
This network shows the impact of papers produced by Kun Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Shang. The network helps show where Kun Shang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kun Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 24 | |
| 8 | 2024 | 23 | |
| 9 | 2024 | 12 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 28 | |
| 12 | 2023 | 15 | |
| 13 | 2022 | 47 | |
| 14 | 2022 | 124 | |
| 15 | 2022 | 57 |
About Kun Shang
Kun Shang is a scholar working on Immunology, Physiology and Biomedical Engineering, having authored 15 papers that have together received 376 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), interferon and immune responses (4 papers), Photodynamic Therapy Research Studies (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lanthanide and Transition Metal Complexes (2 papers), Cancer therapeutics and mechanisms (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Immunology (146 citations), Biomaterials (72 citations) and Biomedical Engineering (211 citations). Kun Shang has collaborated with scholars based in China, Australia and Germany. Frequent co-authors include Dongsheng Tang, Hongbin Han, Haihua Xiao, Lingpu Zhang, Juan Chen, Man Fang, Lei Cao, Ji‐Ye Yin, Yingjie Yu and Haihua Xiao. Their work appears in journals such as Advanced Materials, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.